Please see our instructional videos below for guidance and information on Leukaemia.
Dr Ailsa Holroyd presents some of her research into BCR signalling and the functional impact of mTor kinase inhibitors on BCR signalling.
An insight into the lab. CLL is a disease of uncontrolled proliferation. Proliferation centres which are within the lymph nodes and bone marrow provide protective signals which enables CLL cells to survive, proliferate and repopulate the blood. CLL cells depend on interactions with microenvironment for their survival.
Dr Alison McCraig Affiliate (Paul O'Gorman Leukaemia Research Centre) Glasgow University In this presentation Dr Alison McCraig looks at the challenges that need to be addressed: more effective treatments less toxic, preferably oral, and identify patients who will not respond well to current treatments
Dr Alison McCraig Affiliate (Paul O'Gorman Leukaemia Research Centre) Glasgow University This presentation gives an overview of CLL from diagnosis, through clinical symptoms and complications, staging, indications for treatment and the pathogenesis of CLL.
Presentation by our keynote Speaker, Claire Dearden, Consultant Haematologist, Head of the CLL Unit, BSc MBBS FRCP FRCPath 'Understanding CLL – How to treat in 2016 and beyond’ followed by Q&A
